NO954318L - Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener - Google Patents

Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener

Info

Publication number
NO954318L
NO954318L NO954318A NO954318A NO954318L NO 954318 L NO954318 L NO 954318L NO 954318 A NO954318 A NO 954318A NO 954318 A NO954318 A NO 954318A NO 954318 L NO954318 L NO 954318L
Authority
NO
Norway
Prior art keywords
antigens
prevention
producing
treatment
well
Prior art date
Application number
NO954318A
Other languages
English (en)
Norwegian (no)
Other versions
NO954318D0 (no
Inventor
Ian Livey
Brian Crowe
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO954318D0 publication Critical patent/NO954318D0/no
Publication of NO954318L publication Critical patent/NO954318L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO954318A 1993-04-29 1995-10-27 Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener NO954318L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5386393A 1993-04-29 1993-04-29
PCT/EP1994/001365 WO1994025596A2 (en) 1993-04-29 1994-04-29 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS

Publications (2)

Publication Number Publication Date
NO954318D0 NO954318D0 (no) 1995-10-27
NO954318L true NO954318L (no) 1995-12-29

Family

ID=21987063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954318A NO954318L (no) 1993-04-29 1995-10-27 Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener

Country Status (16)

Country Link
EP (1) EP0701612B1 (xx)
JP (1) JPH08509371A (xx)
AT (1) ATE162550T1 (xx)
AU (1) AU683260B2 (xx)
CA (1) CA2161534A1 (xx)
CZ (1) CZ289212B6 (xx)
DE (1) DE69408135T2 (xx)
DK (1) DK0701612T3 (xx)
ES (1) ES2114687T3 (xx)
FI (1) FI955150A (xx)
HR (1) HRP940279B1 (xx)
HU (1) HU217024B (xx)
NO (1) NO954318L (xx)
PL (1) PL178775B1 (xx)
SK (1) SK279968B6 (xx)
WO (1) WO1994025596A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5915049A (en) * 1992-02-25 1999-06-22 Pfu Limited Binarization system for an image scanner
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
DE69718903T2 (de) * 1996-05-02 2003-12-04 Dakocytomation Denmark As Glos Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
AT405940B (de) * 1996-06-21 1999-12-27 Immuno Ag Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein
DE19629543C2 (de) * 1996-07-22 1999-02-11 Immuno Ag Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
ATE386805T1 (de) 1998-07-31 2008-03-15 Gundersen Lutheran Medical Fou Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
WO2000078966A1 (en) * 1999-06-18 2000-12-28 Research Foundation Of State University Of New York Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
AU2001285049A1 (en) 2000-08-18 2002-03-04 Brookhaven Sciences Associates, Llc Altered ospa of borrelia burgdorferi
GB2414667A (en) 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
EP1957520A4 (en) * 2005-11-29 2009-05-27 Univ Virginia Commonwealth POLYVALENTIC CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN
EP2077856B1 (en) * 2006-11-03 2015-08-12 Intervet International BV Canine lyme disease vaccine
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease

Also Published As

Publication number Publication date
AU6722994A (en) 1994-11-21
JPH08509371A (ja) 1996-10-08
FI955150A0 (fi) 1995-10-27
WO1994025596A2 (en) 1994-11-10
PL178775B1 (pl) 2000-06-30
HRP940279A2 (en) 1997-10-31
SK279968B6 (sk) 1999-06-11
CZ289212B6 (cs) 2001-12-12
CA2161534A1 (en) 1994-11-10
EP0701612B1 (en) 1998-01-21
PL311301A1 (en) 1996-02-05
DE69408135T2 (de) 1998-06-10
ES2114687T3 (es) 1998-06-01
DK0701612T3 (da) 1998-09-21
NO954318D0 (no) 1995-10-27
AU683260B2 (en) 1997-11-06
HUT72923A (en) 1996-06-28
HU9502002D0 (en) 1995-08-28
EP0701612A1 (en) 1996-03-20
WO1994025596A3 (en) 1994-12-22
SK134195A3 (en) 1996-05-08
FI955150A (fi) 1995-12-28
ATE162550T1 (de) 1998-02-15
DE69408135D1 (de) 1998-02-26
CZ283995A3 (en) 1996-03-13
HRP940279B1 (en) 2000-12-31
HU217024B (hu) 1999-11-29

Similar Documents

Publication Publication Date Title
NO954318L (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
DE69536091D1 (de) Immunisierung durch Impfung von DNS Transkriptionseinheit
WO2000020027A3 (en) Methods for therapeutic vaccination
NO20002413L (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
DK0598816T3 (da) Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
CA2245497A1 (en) Peptide immunogens for vaccination against and treatment of allergy
IT1237764B (it) Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
CA2001328A1 (en) Borrelia antigen
NO20014624L (no) Fremgangsmåte for fremstilling av monoklonale antistoffer og fremgangsmåte for fremstilling av vaksine mot Lyme-sykdom(borreliose)
CA2132836A1 (en) Immunization by inoculation of dna transcription unit
NO924780L (no) Ekspresjon av spesifikke immunogener ved bruk av virusantigener
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
DK0555276T3 (da) Immunogene komplekser, især iscomer
EP0232798A3 (en) Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
AU1800597A (en) Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
EP0372928A3 (en) Heat-labile toxin b subunit fusion proteins
ATE206138T1 (de) Helicobacter pylori antigen
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor
SE9600646D0 (sv) Vaccin
MX9700215A (es) Proteinas y vacunas de helicobacter.
YU24401A (sh) Novi postupci za terapeutsku vakcinaciju

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application